Abstract:e13597 Background: Accurate identification of tumor origin is crucial for effective diagnosis and treatment, particularly in cases of metastatic tumors. Interpretable machine learning models have displayed significant potential in addressing this problem when imaging and immunohistochemistry (IHC) examinations are ineffective. In this study, we developed a panel using gene expression profiles from various tumors and constructed a robust machine learning model for precise identification of tumor origin. Methods: RNA sequencing (RNA-seq) data of 9462 tumor samples originating from 21 different organs were collected from The Cancer Genome Atlas (TCGA). We conducted feature engineering through unsupervised clustering and differential gene expression analysis, selecting a refined panel of 164 genes from a pool of over 60,000 identifiers. Subsequently, a machine learning classifier grounded in Logistic regression (LR) was trained on 9462 samples with the constructed 164-gene panel. To enhance the adaptability of our model to this task, 10-fold cross-validation was employed in the multi-class mode. Two independent test sets, the Primary tumor set (PT, n=3420, including 19 tumor types) and the Metastatic tumor set (MTP, n=100, all originating from the prostate and spread to bone, liver, etc.), were established with samples from Gene Expression Omnibus (GEO) and other published studies. Notably, all samples underwent FPKM normalization and there was no overlap between training and testing samples. Model performance was assessed using accuracy, specificity, and sensitivity metrics. Results: The 164-gene expression panel achieved a cross-validation accuracy of 96.73%. In the assessment of the PT test set, our model achieved an overall 99.62% specificity, 92.31% accuracy and 89.79% sensitivity, exhibiting performance comparable to similar models in other studies. Additionally, our model accurately traced 91% of metastatic tumors in the MTP test set to the prostate, surpassing previous lines of work by a large margin. Conclusions: Gene expression patterns reveal organ-specific characteristics that could be used to identify tumor origin. The combination of a condensed yet comprehensive gene expression panel with a robust machine learning model serves as a promising tool for tumor diagnosis. Ongoing correlative studies aim to extend predictions from tissue organs to cancer subtypes.

Factor Analysis for Cross-Platform Tumor Classification Based on Gene Expression Profiles

The Classification of Tumor Using Gene Expression Profile Based on Support Vector Machines and Factor Analysis.

Feature Extraction from Tumor Gene Expression Profiles Using DCT and DFT

Computational Methods for Gene Expression-Based Tumor Classification

Using 2d principal component analysis to reduce dimensionality of gene expression profiles for tumor classification

Research of a Tumor Diagnosis Algorithm Based on Principal Component Analysis

Tumor Classification Based on Non-Negative Matrix Factorization Using Gene Expression Data

A novel approach to feature extraction from classification models based on information gene pairs

Molecular Diagnosis of Tumor Based on Independent Component Analysis and Support Vector Machines

Independent Component Analysis-Based Penalized Discriminant Method for Tumor Classification Using Gene Expression Data.

Subtype Dependent Biomarker Identification and Tumor Classification from Gene Expression Profiles.

A Method for Cancer Classification Using Ensemble Neural Networks with Gene Expression Profile

Tumor Feature Extraction Based on LoG Matrix Factorization

Tumor origin identification through machine learning and gene expression profiling.

RPCA-Based Tumor Classification Using Gene Expression Data

Cancer Classification Using Entropy Analysis in Fractional Fourier Domain of Gene Expression Profile

Cancer prediction with gene expression profiling and differential evolution

Feature (gene) Selection in Gene Expression-Based Tumor Classification

Generalized Discriminant Analysis for Tumor Classification with Gene Expression Data

Tumor Classification Based on Partial Least Square Regression

Study of Informative Gene Selection for Tissue Classification Based on Tumor Gene Expression Profiles